Agoracom: Small Cap Investment - Resverlogix Corp. - Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

paladin

Rank: President [?]

Points: 1992 [?]

Votes: 26 Score: 3.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial

in response to

Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial

jbuffett62

posted on Dec 22, 2020 10:16AM

Coincidentally there is also an article on CNNs website this morning on 'Hunting for Disease X' and where a doctor who discovered Ebola warns of deadly viruses yet to come. If so COVID is unlikely to be just another flash in the 100 year pan.

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply